Alexander V Mayweg

USPTO Granted Patents = 6 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 10.9

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

6 out of 4,955

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2014-2016

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9353081 - Bicyclic dihydroquinoline-2-one derivatives (2016-05-31),

2. 9260408 - Dihydroquinoline-2-one derivatives (2016-02-16),

3. 9242943 - 1,4 oxazines as BACE1 and/or BACE2 inhibitors (2016-01-26),

4. 9187429 - Phenyl-tetrahydroisoquinoline derivatives (2015-11-17),

5. 9133158 - Bicyclic dihydroisoquinoline-1-one derivatives (2015-09-15),

6. 8748418 - 1,4-oxazepines as BACE1 and/or BACE2 inhibitors (2014-06-10),

Title: Alexander V Mayweg: Pioneering Inventor from Shanghai

Introduction: Alexander V Mayweg is a distinguished inventor based in Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Alexander V Mayweg holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his innovative mindset and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Alexander V Mayweg has worked with leading research institutions and multinational companies, playing a key role in developing cutting-edge technologies that have revolutionized industries.

Collaborations: Throughout his career, Alexander V Mayweg has collaborated with top scientists, engineers, and researchers from around the globe, fostering a culture of innovation and knowledge exchange.

Conclusion: Alexander V Mayweg's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.